Prescription Telmisartan Recalled for Failed Blend Uniformity Specifications
Micro Labs Limited is recalling 118,080 bottles of Telmisartan 40mg tablets due to failed blend uniformity specifications. The affected lots (SFBG024, SFBG025) were distributed in Puerto Rico, Tennessee, and Rhode Island.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II recall involving a prescription blood pressure medication with a manufacturing defect (blend uniformity failure) that could result in variable drug doses. Although no illnesses or injuries have been reported, the defect creates a potential risk of treatment failure or adverse effects. Per the rubric, risk-of-harm products without reported injury are classified as High.
Plain-English summary
Micro Labs Limited is recalling 118,080 bottles of Telmisartan 40mg tablets due to failed stability specifications for blend uniformity. The affected lot numbers are SFBG024 and SFBG025, with an expiration date of May 31, 2024. The product was manufactured by Micro Labs Limited in Goa, India, for Micro Labs USA Inc. in Somerset, New Jersey.
The recall was issued because the tablets failed testing for blend uniformity, meaning the active ingredient telmisartan is not evenly distributed within the affected batches. This manufacturing defect could result in some tablets containing inconsistent amounts of the active ingredient compared to the labeled 40mg dose.
The affected tablets were distributed to Puerto Rico, Tennessee, and Rhode Island. Patients currently taking the recalled lot numbers should contact their pharmacy or healthcare provider for guidance on obtaining replacement medication.
The recalled product
- Product
- TELMISARTAN (TELMISARTAN)
- Brand
- TELMISARTAN
- Manufacturer
- Micro Labs Limited
- Category
- Drug
- Hazard
- blend-uniformity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #s: SFBG024
- SFBG025
- Exp. 05/31/2024
UPCs (3)
- 0342571228309
- 0342571226305
- 0342571227302
Distribution
Distributed in 2 states:
- RI
- TN
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereChloraPrep One-Step Sterile Solution Lacks Assurance of Sterility
FDA (Drugs) · 2026-07-08
- SevereLidocaine Hydrochloride Injection Recalled for Sterility Assurance
FDA (Drugs) · 2026-07-08
- ModerateMedline Convenience Kits Block Tray recalled due to quality defects
FDA (Devices) · 2026-07-08
- SevereChloraPrep One-Step Applicators Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-08